MAPT and Alzheimer disease: No significant changes in CAMKK2 or TF charge states were detected.<h4>Discussion</h4>CAMKK2 downregulation and impaired iron transport appear to be shared features across multiple neurodegenerative diseases, but their decoupling from tau pathology seems specific to AD.